Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 42
Filter
1.
Biomed Res Int ; 2020: 4281802, 2020.
Article in English | MEDLINE | ID: mdl-33204696

ABSTRACT

We aimed to investigate the effects of chronic fluid restriction and hydration with a sweetened beverage (SB) in rats from weaning until adolescence, in a posterior acute kidney injury (AKI) event induced by ischemia-reperfusion (I/R). We followed 5 groups of weaning rats: control group (C); two groups with 22 h/day fluid restriction, a group hydrated for two hours with water (-W) and a group hydrated with SB; one group receiving SB ad libitum all day (+SB); and one group in which water consumption was increased using a gel diet. The rats that reached adolescence were submitted to I/R. Fluid restriction and/or SB hydration induced mild renal alterations that were significantly accentuated in the -SB group and resulted in worse outcomes after I/R-induced AKI that resulted in a catastrophic fall in creatinine clearance and diffuse acute tubular necrosis. In summary, low tap water intakes, as well as SB intake in infancy, prompt kidney worse outcomes in a later event of AKI during adolescence and both insults magnify kidney damage. Studies on hydration habits in children are recommended to disclose the potentially harmful effects that those behavioral patterns might carry to future renal health.


Subject(s)
Acute Kidney Injury/etiology , Drinking , Fructose/pharmacology , Animals , Artificially Sweetened Beverages , Fructokinases/metabolism , Fructose/adverse effects , Kidney/metabolism , Kidney/pathology , Kidney Function Tests , Lipid Peroxidation , Lipocalin-2/metabolism , Male , Organism Hydration Status , Rats, Wistar , Receptor, Angiotensin, Type 1/metabolism , Reperfusion Injury/complications , Reperfusion Injury/etiology
2.
Transplant Proc ; 52(4): 1127-1131, 2020 May.
Article in English | MEDLINE | ID: mdl-32307138

ABSTRACT

The main complication associated with renal graft loss is immune rejection. The gold standard for the diagnosis of renal graft rejection is percutaneous renal biopsy, which is expensive and can lead to complications. Inflammation is one of the main pathogenic pathways in allograft rejection, and urine samples seem to be efficient windows to explore the allograft condition with a high cost-benefit ratio. This study aimed to evaluate the messenger ribonucleic acid (mRNA) profile expression pattern for interleukin (IL) 2, IL-4, IL-6, IL-8, and IL-10; tumor necrosis factor alfa; gamma interferon; and transforming growth factor ß1 in the urine renal cells of patients with a diagnosis of humoral rejection and patients with a diagnosis of normal biopsy. METHODS: An observational, cross-sectional analytical study was performed. All kidney transplants were performed at the Organ Transplant Department between 2018 and 2019. Also, a healthy control with a normal blood test and no apparent infection was included. mRNA from urine samples and biopsies was isolated, and the expression of interleukins was analyzed in PCR real time. Data were analyzed by Shapiro-Wilk and Kruskal-Wallis tests. RESULTS: The proinflammatory IL expression pattern in urine samples of kidney rejection group showed overexpression for IL-8 (P = .0001). No differences were observed in the rest of the interleukins analyzed. When we compared the results in the rejected versus not rejected transplanted patients with a group of apparently healthy subjects, the difference remains consistent. Thus, mRNA of IL-8 could function as a diagnostic tool in cases of chronic damage secondary to fibrosis.


Subject(s)
Biomarkers/urine , Graft Rejection/urine , Interleukin-8/urine , Kidney Transplantation/adverse effects , Adult , Cross-Sectional Studies , Female , Graft Rejection/diagnosis , Graft Rejection/immunology , Humans , Interleukin-8/immunology , Male , Middle Aged , Sensitivity and Specificity , Transplantation, Homologous
3.
Transplant Proc ; 52(4): 1132-1135, 2020 May.
Article in English | MEDLINE | ID: mdl-32249055

ABSTRACT

Kidney transplant (KT) is the first therapeutic option for most patients with chronic renal failure that requires renal function replacement. The main complication associated with renal graft loss is immune rejection. The T regulatory pathways play a key role in this process, and abnormalities in some of these molecules could participate in the graft rejection. In this paper, our group performed an exploratory analysis of the behavior of the coinducible molecules (CD28, CTLA-4, ICOS, PD-1) in patients with KT rejection and control KT patients without rejection. The Mann-Whitney U test, used for 2 groups, showed significant differences (P = .0005), indicating that PD-1 is underexpressed in patients with allograft rejection. No differences were found in CD28+, regulatory T cells (T reg), CTLA-4, and ICOS, so we are proposing that PD-1 is a key player in the immunotolerance phenomenon and its underexpression participates in the rejection process. More research needs to be performed on this topic.


Subject(s)
Graft Rejection/immunology , Kidney Transplantation , Programmed Cell Death 1 Receptor/immunology , Transplantation Immunology/immunology , Adult , Cross-Sectional Studies , Female , Humans , Male , T-Lymphocytes, Regulatory/immunology , Transplantation, Homologous
4.
BMC Nephrol ; 21(1): 87, 2020 03 06.
Article in English | MEDLINE | ID: mdl-32143585

ABSTRACT

BACKGROUND: Interstitial fibrosis (IF) on kidney biopsy is one of the most potent risk factors for kidney disease progression. The furosemide stress test (FST) is a validated tool that predicts the severity of acute kidney injury (especially at 2 h) in critically ill patients. Since furosemide is secreted through the kidney tubules, the response to FST represents the tubular secretory capacity. To our knowledge there is no data on the correlation between functional tubular capacity assessed by the FST with IF on kidney biopsies from patients with chronic kidney disease (CKD). The aim of this study was to determine the association between urine output (UO), Furosemide Excreted Mass (FEM) and IF on kidney biopsies after a FST. METHODS: This study included 84 patients who underwent kidney biopsy for clinical indications and a FST. The percentage of fibrosis was determined by morphometry technique and reviewed by a nephropathologist. All patients underwent a FST prior to the biopsy. Urine volume and urinary sodium were measured in addition to urine concentrations of furosemide at different times (2, 4 and 6 h). We used an established equation to determine the FEM. Values were expressed as mean, standard deviation or percentage and Pearson Correlation. RESULTS: The mean age of the participants was 38 years and 44% were male. The prevalence of diabetes mellitus, hypertension and diuretic use was significantly higher with more advanced degree of fibrosis. Nephrotic syndrome and acute kidney graft dysfunction were the most frequent indications for biopsy. eGFR was inversely related to the degree of fibrosis. Subjects with the highest degree of fibrosis (grade 3) showed a significant lower UO at first hour of the FST when compared to lower degrees of fibrosis (p = 0.015). Likewise, the total UO and the FEM was progressively lower with higher degrees of fibrosis. An inversely linear correlation between FEM and the degree of fibrosis (r = - 0.245, p = 0.02) was observed. CONCLUSIONS: Our findings indicate that interstitial fibrosis correlates with total urine output and FEM. Further studies are needed to determine if UO and FST could be a non-invasive tool to evaluate interstitial fibrosis. TRIAL REGISTRATION: ClinicalTrials.gov NCT02417883.


Subject(s)
Furosemide/urine , Kidney Tubules, Proximal/physiopathology , Kidney/pathology , Renal Insufficiency, Chronic/pathology , Renal Insufficiency, Chronic/physiopathology , Sodium Potassium Chloride Symporter Inhibitors/urine , Adult , Biopsy/methods , Disease Progression , Female , Fibrosis , Furosemide/administration & dosage , Humans , Male , Prognosis , Renal Insufficiency, Chronic/urine , Risk Factors , Sodium/urine , Sodium Potassium Chloride Symporter Inhibitors/administration & dosage
5.
Nephron ; 143(4): 264-273, 2019.
Article in English | MEDLINE | ID: mdl-31487709

ABSTRACT

INTRODUCTION: Tlaxcala, a small state in central Mexico, has the highest prevalence of chronic kidney disease (CKD) deaths in population aged 5-14 in Mexico, most of them with unknown etiology. OBJECTIVE: To determine the prevalence of CKD in apparently healthy pediatric population in Apizaco, Tlaxcala. METHODS: A cross-sectional pilot study was carried out in children deemed as healthy; subjects with previous diagnosis of CKD were excluded. Informed consent was obtained in all cases. A physical examination was performed, a questionnaire was applied. Blood and urine samples were obtained for serum creatinine, urinalysis, and microalbumin/creatinine ratio. A second and third evaluation was performed after 6 and 18 months in those found with urinary anomalies/CKD to confirm the diagnosis. RESULTS: One hundred and nine subjects completed physical examination, which are the biological samples. Median age was 12 years. CKD stage 2 was confirmed in 5 subjects in the sixth month confirmation visit (4.6%). One patient accepted renal biopsy and Alport Syndrome was found. In a robust multivariate analysis, the risk factors related to reduction in the glomerular filtration rate were males -5.15 mL/min/1.73 m2 (p = 0.002), older participants as by -1.58 mL/min/1.73 m2 per year (p < 0.0001), and among participants living close to a river -3.76 mL/min/1.73 m2 (p = 0.033). DISCUSSION/CONCLUSION: The prevalence of CKD in the population studied in Apizaco Tlaxcala was confirmed in 4.6 cases per 100 inhabitants between 6 and 15 years. Males, older age, and living close to a river were the risk predictive factors. More studies are needed to determine the causes of the high CKD prevalence in this population.


Subject(s)
Renal Insufficiency, Chronic/epidemiology , Adolescent , Child , Cross-Sectional Studies , Environmental Pollutants/toxicity , Female , Glomerular Filtration Rate , Humans , Kidney/pathology , Male , Mexico/epidemiology , Pilot Projects , Prevalence , Renal Insufficiency, Chronic/pathology , Renal Insufficiency, Chronic/physiopathology , Risk Factors
6.
PLoS One ; 13(8): e0202901, 2018.
Article in English | MEDLINE | ID: mdl-30142173

ABSTRACT

Hyperuricemia is highly prevalent and especially common in subjects with metabolic, cardiovascular and renal diseases. In chronic kidney disease, hyperuricemia is extremely common, and uric acid (UA) excretion relies on gut uricolysis by gut microbiota. Current therapy for lowering serum UA includes drugs that may produce undesired secondary effects. Therefore, this pilot study was designed to evaluate the potential of two probiotic supplements to reduce systemic uric acid concentrations. Secondary objectives were to assess whether the hypouricemic effect related to a therapeutic benefit on the hyperuricemia-induced renal damage and hypertension. Analysis of fecal microbiota was also performed. Groups of 6 rats each were followed for 5 weeks and allocated in the following treatment groups: C = Control; HU-ND = Oxonic acid-induced hyperuricemia (HU) +regular diet; HU-P = HU+placebo; HU-F1 = HU+ probiotics formula 1 and HU-F2 = HU+ probiotics formula 2. We confirmed that oxonic acid-induced hyperuricemia produced hypertension and renal functional and structural changes, along with modest changes in the overall composition of fecal microbiota. Both probiotic-containing diets prevented HU, elevated UA urinary excretion and intrarenal UA accumulation induced by oxonic acid. The hypouricemic effect conferred by probiotic supplementation also prevented the renal changes and hypertension caused by hyperuricemia. However, probiotic treatment did not restore the fecal microbiota. In conclusion, we demonstrated for the first time the ability of probiotics containing uricolytic bacteria to lower serum uric acid in hyperuricemic animals with beneficial consequences on blood pressure and renal disease. As probiotics supplements are innocuous for human health, we recommend clinical studies to test if probiotic supplements could benefit hyperuricemic individuals.


Subject(s)
Dietary Supplements , Hyperuricemia/chemically induced , Hyperuricemia/prevention & control , Kidney/drug effects , Kidney/injuries , Oxonic Acid/adverse effects , Probiotics/pharmacology , Animals , Cytoprotection/drug effects , Dose-Response Relationship, Drug , Hyperuricemia/metabolism , Hyperuricemia/pathology , Kidney/metabolism , Kidney/pathology , Male , Oxidative Stress/drug effects , Pilot Projects , Rats , Rats, Wistar , Uric Acid/metabolism
7.
Int J Biol Sci ; 13(8): 961-975, 2017.
Article in English | MEDLINE | ID: mdl-28924378

ABSTRACT

Recurrent dehydration and heat stress cause chronic kidney damage in experimental animals. The injury is exacerbated by rehydration with fructose-containing beverages. Fructose may amplify dehydration-induced injury by directly stimulating vasopressin release and also by acting as a substrate for the aldose reductase-fructokinase pathway, as both of these systems are active during dehydration. The role of vasopressin in heat stress associated injury has not to date been explored. Here we show that the amplification of renal damage mediated by fructose in thermal dehydration is mediated by vasopressin. Fructose rehydration markedly enhanced vasopressin (copeptin) levels and activation of the aldose reductase-fructokinase pathway in the kidney. Moreover, the amplification of the renal functional changes (decreased creatinine clearance and tubular injury with systemic inflammation, renal oxidative stress, and mitochondrial dysfunction) were prevented by the blockade of V1a and V2 vasopressin receptors with conivaptan. On the other hand, there are also other operative mechanisms when water is used as rehydration fluid that produce milder renal damage that is not fully corrected by vasopressin blockade. Therefore, we clearly showed evidence of the cross-talk between fructose, even at small doses, and vasopressin that interact to amplify the renal damage induced by dehydration. These data may be relevant for heat stress nephropathy as well as for other renal pathologies due to the current generalized consumption of fructose and deficient hydration habits.


Subject(s)
Fructose/metabolism , Kidney/metabolism , Kidney/pathology , Renal Insufficiency, Chronic/metabolism , Vasopressins/metabolism , Animals , Blood Pressure/physiology , Body Weight , Hemodynamics/physiology , Immunohistochemistry , Male , Oxidative Stress/physiology , Rats , Receptors, Vasopressin/metabolism
8.
Cell Biol Int ; 41(12): 1356-1366, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28884894

ABSTRACT

Heavy metal ions are known to produce harmful alterations on kidney function. Specifically, the accumulation of Hg2+ in kidney tissue may induce renal failure. In this work, the protective effect of CDP-choline against the deleterious effects induced by Hg2+ on renal function was studied. CDP-choline administered ip at a dose of 125 mg/kg body weight prevented the damage induced by Hg2+ administration at a dose of 3 mg/kg body weight. The findings indicate that CDP-choline guards mitochondria against Hg2+ -toxicity by preserving their ability to retain matrix content, such as accumulated Ca2+ . This nucleotide also protected mitochondria from Hg2+ -induced loss of the transmembrane electric gradient and from the generation of hydrogen peroxide and membrane TBARS. In addition, CDP-choline avoided the oxidative damage of mtDNA and inhibited the release of the interleukins IL-1 and IL6, recognized as markers of acute inflammatory reaction. After the administration of Hg2+ and CDP, CDP-choline maintained nearly normal levels of renal function and creatinine clearance, as well as blood urea nitrogen (BUN) and serum creatinine.


Subject(s)
Cytidine Diphosphate Choline/pharmacology , Kidney/drug effects , Mercury/toxicity , Mitochondria/drug effects , Animals , Creatine/metabolism , Interleukin-1/metabolism , Interleukin-6/metabolism , Kidney/metabolism , Kidney/pathology , Kidney Function Tests , Male , Membrane Potentials/drug effects , Mitochondria/metabolism , Mitochondria/pathology , Oxidation-Reduction , Rats , Rats, Wistar , Thiobarbituric Acid Reactive Substances/metabolism
9.
Free Radic Res ; 50(7): 781-92, 2016 Jul.
Article in English | MEDLINE | ID: mdl-27050624

ABSTRACT

Increased oxidative stress and inflammation have an important role in the pathophysiology of chronic kidney disease (CKD). On the other hand, more affordable therapeutic alternatives for treating this disease are urgently needed. Therefore, we compared the therapeutic efficacy of curcumin and mycophenolate mofetil (MMF) in 5/6 nephrectomy (5/6 Nx) model of CKD. Also, we evaluated whether both compounds provide benefit through the preservation of similar antioxidant mechanisms. Four groups of male Wistar were studied over a period of 4 wk. Control sham group (n= 12), 5/6 Nx (n = 12), 5/6 Nx + MMF (30 mg/k BW/day, n = 11) and 5/6 Nx + Curcumin (120 mg/k BW/day, n = 12). Renal function and markers of oxidative stress and inflammation were evaluated. Also Nrf2-Keap1 and renal dopamine, antioxidant pathways were assessed. 5/6 Nx induced an altered renal autoregulation response, proteinuria, and hypertension; these effects were in association with increased oxidative stress, endothelial dysfunction and renal inflammation. The mechanisms associated with these alterations included a reduced nuclear translocation of Nrf2 and hyperphosphorylation of dopamine D1 receptor with a concurrent overactivation of renal NADPH oxidase. Treatments with MMF and curcumin provided equivalent therapeutic efficacy as both prevented functional renal alterations as well as preserved antioxidant capacity and avoided renal inflammatory infiltration. Moreover, both treatments preserved Nrf2-Keap1 and renal dopamine antioxidant pathways. In summary, therapeutic strategies aimed to preserve renal antioxidant pathways can help to retard the progression of CKD.


Subject(s)
Curcumin/pharmacology , Dopamine/metabolism , Kelch-Like ECH-Associated Protein 1/metabolism , Mycophenolic Acid/pharmacology , NF-E2-Related Factor 2/metabolism , Renal Insufficiency, Chronic/drug therapy , Animals , Male , Oxidative Stress/drug effects , Rats , Rats, Wistar , Renal Insufficiency, Chronic/metabolism , Renal Insufficiency, Chronic/pathology
10.
Am J Physiol Regul Integr Comp Physiol ; 311(1): R57-65, 2016 07 01.
Article in English | MEDLINE | ID: mdl-27053647

ABSTRACT

Recurrent dehydration, such as commonly occurs with manual labor in tropical environments, has been recently shown to result in chronic kidney injury, likely through the effects of hyperosmolarity to activate both vasopressin and aldose reductase-fructokinase pathways. The observation that the latter pathway can be directly engaged by simple sugars (glucose and fructose) leads to the hypothesis that soft drinks (which contain these sugars) might worsen rather than benefit dehydration associated kidney disease. Recurrent dehydration was induced in rats by exposure to heat (36°C) for 1 h/24 h followed by access for 2 h to plain water (W), a 11% fructose-glucose solution (FG, same composition as typical soft drinks), or water sweetened with noncaloric stevia (ST). After 4 wk plasma and urine samples were collected, and kidneys were examined for oxidative stress, inflammation, and injury. Recurrent heat-induced dehydration with ad libitum water repletion resulted in plasma and urinary hyperosmolarity with stimulation of the vasopressin (copeptin) levels and resulted in mild tubular injury and renal oxidative stress. Rehydration with 11% FG solution, despite larger total fluid intake, resulted in greater dehydration (higher osmolarity and copeptin levels) and worse renal injury, with activation of aldose reductase and fructokinase, whereas rehydration with stevia water had opposite effects. In animals that are dehydrated, rehydration acutely with soft drinks worsens dehydration and exacerbates dehydration associated renal damage. These studies emphasize the danger of drinking soft drink-like beverages as an attempt to rehydrate following dehydration.


Subject(s)
Carbonated Beverages/adverse effects , Dehydration/chemically induced , Fluid Therapy/adverse effects , Kidney Diseases/chemically induced , Animals , Blood Pressure/drug effects , Dehydration/complications , Fructose/pharmacology , Fructose/urine , Glycopeptides/blood , Hot Temperature/adverse effects , Kidney/drug effects , Kidney/metabolism , Kidney Diseases/pathology , Kidney Function Tests , Male , Oxidative Stress/drug effects , Rats , Rats, Wistar , Stevia , Sweetening Agents/pharmacology , Uric Acid/urine , Water/pharmacology , Water-Electrolyte Balance
11.
Nephron Extra ; 4(2): 119-26, 2014 May.
Article in English | MEDLINE | ID: mdl-25337080

ABSTRACT

BACKGROUND: Type 2 diabetes mellitus (T2DM) is the leading cause of chronic kidney disease and a major cause of cardiovascular disease (CVD) mortality. Inflammation is closely involved in the pathogenesis of T2DM, and reactive amyloidosis occurs in the presence of chronic inflammation. We hypothesized that patients with T2DM may have a higher prevalence of renal AA amyloidosis (RAAA) and that this could contribute to worse atherosclerosis and CVD. MATERIALS AND METHODS: We analyzed 330 autopsy kidneys from patients with a previous T2DM diagnosis. The kidney tissue was evaluated in order to determine the presence of diabetic nephropathy and RAAA, and systemic vessels were evaluated for the presence of atherosclerosis. RESULTS: RAAA was detected in 9% of our study population and was associated with an increased risk for nodular sclerosis [OR (95% CI)] [11 (2.04-59.16)], for chronic ischemic cardiomyopathy [4.59 (2.02-10.42)], for myocardial infarction [3.41 (1.52-7.64)] as well as for aortic [4.75 (1.09-20.69)], coronary [3.22 (1.47-7.04)], and intrarenal atherosclerosis [3.84 (1.46-10.09)]. CONCLUSIONS: RAAA is prevalent in T2DM and is associated with worse CVD and renal disease, likely because RAAA is a marker of severe chronic inflammation.

13.
Free Radic Biol Med ; 61: 119-29, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23548636

ABSTRACT

Curcumin, a natural pigment with antioxidant activity obtained from turmeric and largely used in traditional medicine, is currently being studied in the chemoprevention of several diseases for its pleiotropic effects and nontoxicity. In chronic renal failure, the pathogenic mechanisms leading to cardiovascular disorders have been associated with increased oxidative stress, a process inevitably linked with mitochondrial dysfunction. Thus, in this study we aimed at investigating if curcumin pretreatment exerts cardioprotective effects in a rat model of subtotal nephrectomy (5/6Nx) and its impact on mitochondrial homeostasis. Curcumin was orally administered (120mg/kg) to Wistar rats 7 days before nephrectomy and after surgery for 60 days (5/6Nx+curc). Renal dysfunction was detected a few days after nephrectomy, whereas changes in cardiac function were observed until the end of the protocol. Our results indicate that curcumin treatment protects against pathological remodeling, diminishes ischemic events, and preserves cardiac function in uremic rats. Cardioprotection was related to diminished reactive oxygen species production, decreased oxidative stress markers, increased antioxidant response, and diminution of active metalloproteinase-2. We also observed that curcumin's cardioprotective effects were related to maintaining mitochondrial function. Aconitase activity was significantly higher in the 5/6Nx + curc (408.5±68.7nmol/min/mg protein) than in the 5/6Nx group (104.4±52.3nmol/min/mg protein, P<0.05), and mitochondria from curcumin-treated rats showed enhanced oxidative phosphorylation capacities with both NADH-linked substrates and succinate plus rotenone (3.6±1 vs 1.1±0.9 and 3.1±0.7 vs 1.2±0.8, respectively, P<0.05). The mechanisms involved in cardioprotection included both direct antioxidant effects and indirect strategies that could be related to protein kinase C-activated downstream signaling.


Subject(s)
Curcumin/pharmacology , Heart/drug effects , Mitochondria/drug effects , Renal Insufficiency, Chronic/drug therapy , Animals , Catalase/metabolism , Heart/physiopathology , Kidney/physiopathology , Male , Mitochondria/physiology , NF-E2-Related Factor 2/metabolism , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Renal Insufficiency, Chronic/physiopathology
14.
Am J Physiol Renal Physiol ; 304(6): F727-36, 2013 Mar 15.
Article in English | MEDLINE | ID: mdl-23303409

ABSTRACT

Fructose in sweetened beverages (SB) increases the risk for metabolic and cardiorenal disorders, and these effects are in part mediated by a secondary increment in uric acid (UA). Rodents have an active uricase, thus requiring large doses of fructose to increase plasma UA and to induce metabolic syndrome and renal hemodynamic changes. We therefore hypothesized that the effects of fructose in rats might be enhanced in the setting of uricase inhibition. Four groups of male Sprague-Dawley rats (n = 7/group) were studied during 8 wk: water + vehicle (V), water + oxonic acid (OA; 750 mg/k BW), sweetened beverage (SB; 11% fructose-glucose combination) + V, and SB + OA. Systemic blood pressure, plasma UA, triglycerides (TG), glucose and insulin, glomerular hemodynamics, renal structural damage, renal cortex and liver UA, TG, markers of oxidative stress, mitDNA, fructokinase, and fatty liver synthase protein expressions were evaluated at the end of the experiment. Chronic hyperuricemia and SB induced features of the metabolic syndrome, including hypertension, hyperuricemia, hyperglycemia, and systemic and hepatic TG accumulation. OA alone also induced glomerular hypertension, and SB alone induced insulin resistance. SB + OA induced a combined phenotype including metabolic and renal alterations induced by SB or OA alone and in addition also acted synergistically on systemic and glomerular pressure, plasma glucose, hepatic TG, and oxidative stress. These findings explain why high concentrations of fructose are required to induce greater metabolic changes and renal disease in rats whereas humans, who lack uricase, appear to be much more sensitive to the effects of fructose.


Subject(s)
Beverages/adverse effects , Fructose/adverse effects , Kidney Diseases/etiology , Oxidative Stress/drug effects , Renal Circulation/drug effects , Urate Oxidase/metabolism , Animals , Fatty Liver/etiology , Fructokinases/metabolism , Glucose/adverse effects , Hypertrophy/etiology , Hyperuricemia/chemically induced , Insulin Resistance , Kidney/drug effects , Kidney/pathology , Kidney Diseases/enzymology , Kidney Diseases/pathology , Liver/drug effects , Liver/metabolism , Male , Metabolic Syndrome/etiology , Oxonic Acid , Rats , Rats, Sprague-Dawley , Urate Oxidase/antagonists & inhibitors , Uric Acid/metabolism , Vasoconstriction/drug effects
15.
Nephron Exp Nephrol ; 121(3-4): e71-8, 2012.
Article in English | MEDLINE | ID: mdl-23235493

ABSTRACT

BACKGROUND/AIMS: Endothelial dysfunction is associated with mitochondrial alterations. We hypothesized that uric acid (UA), which can induce endothelial dysfunction in vitro and in vivo, might also alter mitochondrial function. METHODS: Human aortic endothelial cells were exposed to soluble UA and measurements of oxidative stress, nitric oxide, mitochondrial density, ATP production, aconitase-2 and enoyl Co-A hydratase-1 expressions, and aconitase-2 activity in isolated mitochondria were determined. The effect of hyperuricemia induced by uricase inhibition in rats on renal mitochondrial integrity was also assessed. RESULTS: UA-induced endothelial dysfunction was associated with reduced mitochondrial mass and ATP production. UA also decreased aconitase-2 activity and lowered enoyl CoA hydratase-1 expression. Hyperuricemic rats showed increased mitDNA damage in association with higher levels of intrarenal UA and oxidative stress. CONCLUSIONS: UA-induced endothelial dysfunction is associated with mitochondrial alterations and decreased intracellular ATP. These studies provide additional evidence for a deleterious effect of UA on vascular function that could be important in the pathogenesis of hypertension and vascular disease.


Subject(s)
Adenosine Triphosphate/metabolism , Endothelium, Vascular/metabolism , Endothelium, Vascular/pathology , Intracellular Fluid/metabolism , Mitochondria/metabolism , Uric Acid/toxicity , Animals , Cells, Cultured , Endothelium, Vascular/drug effects , Humans , Intracellular Fluid/drug effects , Male , Mitochondria/drug effects , Mitochondria/pathology , Oxidative Stress/drug effects , Oxidative Stress/physiology , Rats , Rats, Sprague-Dawley , Reactive Oxygen Species/metabolism
16.
Oxid Med Cell Longev ; 2012: 269039, 2012.
Article in English | MEDLINE | ID: mdl-22919438

ABSTRACT

Renal injury resulting from renal ablation induced by 5/6 nephrectomy (5/6NX) is associated with oxidant stress, glomerular hypertension, hyperfiltration, and impaired Nrf2-Keap1 pathway. The purpose of this work was to know if the bifunctional antioxidant curcumin may induce nuclear translocation of Nrf2 and prevents 5/6NX-induced oxidant stress, renal injury, decrease in antioxidant enzymes, and glomerular hypertension and hyperfiltration. Four groups of rats were studied: (1) control, (2) 5/6NX, (3) 5/6NX +CUR, and (4) CUR (n = 8-10). Curcumin was given by gavage to NX5/6 +CUR and CUR groups (60 mg/kg/day) starting seven days before surgery. Rats were studied 30 days after NX5/6 or sham surgery. Curcumin attenuated 5/6NX-induced proteinuria, systemic and glomerular hypertension, hyperfiltration, glomerular sclerosis, interstitial fibrosis, interstitial inflammation, and increase in plasma creatinine and blood urea nitrogen. This protective effect was associated with enhanced nuclear translocation of Nrf2 and with prevention of 5/6NX-induced oxidant stress and decrease in the activity of antioxidant enzymes. It is concluded that the protective effect of curcumin against 5/6NX-induced glomerular and systemic hypertension, hyperfiltration, renal dysfunction, and renal injury was associated with the nuclear translocation of Nrf2 and the prevention of both oxidant stress and the decrease of antioxidant enzymes.


Subject(s)
Cell Nucleus/metabolism , Curcumin/pharmacology , Glomerular Filtration Rate/drug effects , Hypertension/prevention & control , Kidney Glomerulus/enzymology , NF-E2-Related Factor 2/metabolism , Oxidative Stress/drug effects , Animals , Antioxidants/metabolism , Blood Urea Nitrogen , Cell Nucleus/drug effects , Creatinine/blood , Hypertension/blood , Hypertension/complications , Hypertension/physiopathology , Kidney Glomerulus/physiopathology , Lipid Peroxidation/drug effects , Male , Mitochondria/drug effects , Mitochondria/metabolism , Nephrectomy , Oxidants/toxicity , Oxygen Consumption/drug effects , Protein Transport/drug effects , Proteinuria/blood , Proteinuria/complications , Proteinuria/physiopathology , Punctures , Rats , Rats, Wistar , Systole/drug effects
17.
BMC Infect Dis ; 12: 194, 2012 Aug 20.
Article in English | MEDLINE | ID: mdl-22905864

ABSTRACT

BACKGROUND: Takayasu's arteritis (TA) is a chronic inflammatory disease affecting the large arteries and their branches; its etiology is still unknown. In individuals suffering from TA, arterial inflammation progresses to stenosis and/or occlusion, leading to organ damage and affecting survival. Relation of TA with Mycobacterium tuberculosis has been known, but there have been only a few systematic studies focusing on this association. The IS6110 sequence identifies the Mycobacterium tuberculosis complex and the HupB establishes the differences between M. tuberculosis and M. bovis. Our objective was to search the presence of IS6110 and HupB genes in aorta of patients with TA. METHODS: We analyzed aorta tissues embedded in paraffin from 5760 autopsies obtained from our institution, we divided the selected samples as cases and controls; CASES: aortic tissues of individuals with Takayasu's arteritis. Control positive: aortic tissues (with tuberculosis disease confirmed) and control negative with other disease aortic (atherosclerosis). RESULTS: Of 181 selected aorta tissues, 119 fulfilled the corresponding criteria for TA, TB or atherosclerosis. Thus 33 corresponded to TA, 33 to tuberculosis (TB) and 53 to atherosclerosis. The mean age was 22 ± 13, 41 ± 19, and 57 ± 10, respectively. IS6110 and HupB sequences were detected in 70% of TA tissues, 82% in tuberculosis, and in 32% with atherosclerosis. Important statistical differences between groups with TA, tuberculosis versus atherosclerosis (p = 0.004 and 0.0001, respectively) were found. CONCLUSION: We identified a higher frequency of IS6110 and HupB genes in aortic tissues of TA patients. This data suggests that arterial damage could occur due to previous infection with M. tuberculosis.


Subject(s)
Aorta/metabolism , Aorta/microbiology , Bacterial Proteins/metabolism , Histones/metabolism , Mycobacterium bovis/metabolism , Mycobacterium tuberculosis/metabolism , Takayasu Arteritis/metabolism , Takayasu Arteritis/microbiology , Adolescent , Adult , Aged , Child , Female , Humans , In Vitro Techniques , Male , Middle Aged , Young Adult
18.
Kidney Blood Press Res ; 35(4): 273-80, 2012.
Article in English | MEDLINE | ID: mdl-22378379

ABSTRACT

BACKGROUND: Sildenafil treatment ameliorates progressive renal injury resulting from extensive renal ablation; however, modifications induced by sildenafil in the glomerular hemodynamic pathophysiology of the remnant kidney have not been investigated. AIM: To determine the effects of sildenafil in the glomerular microcirculation and their relation to histological damage in the renal ablation model. METHODS: Micropuncture studies were performed 60 days after 5/6 nephrectomy in rats that received no treatment, sildenafil (5 mg/kg/day) and reserpine, hydralazine and hydrochlorothiazide to maintain the blood pressure within normal levels. Sham-operated rats untreated and treated with sildenafil served as controls. RESULTS: As expected, renal ablation induced systemic and glomerular hypertension, hyperfiltration, proteinuria, glomerulosclerosis and tubulointerstitial inflammatory damage in the remnant kidney. Sildenafil treatment prevented single-nephron hyperfiltration and hypertension, suppressed renal arteriolar remodeling, ameliorated systemic hypertension and proteinuria, increased urinary excretion of cGMP and NO(2)(-)/NO(3)(-), decreased oxidative stress and improved histological damage in the remnant kidney. Normalization blood pressure with reserpine, hydralazine and hydrochlorothiazide did not modify glomerular hemodynamics, proteinuria or histological changes induced by renal ablation. CONCLUSIONS: Beneficial effects of sildenafil in the remnant kidney are associated with a reduction in the arteriolar remodeling, renal inflammatory changes and prevention of changes in the glomerular microcirculation.


Subject(s)
Hypertension/prevention & control , Hypertension/surgery , Kidney Glomerulus/drug effects , Kidney Glomerulus/surgery , Nephrectomy , Piperazines/therapeutic use , Sulfones/therapeutic use , Animals , Hypertension/pathology , Kidney Glomerulus/pathology , Male , Piperazines/pharmacology , Purines/pharmacology , Purines/therapeutic use , Rats , Rats, Wistar , Sildenafil Citrate , Sulfones/pharmacology , Treatment Outcome , Vasodilator Agents/pharmacology , Vasodilator Agents/therapeutic use
19.
Semin Nephrol ; 31(5): 426-32, 2011 Sep.
Article in English | MEDLINE | ID: mdl-22000649

ABSTRACT

Excessive fructose consumption is associated with the development of metabolic syndrome and type II diabetes. Both conditions are well-known risk factors for cardiovascular and renal diseases. Uric acid synthesis is linked biochemically to fructose metabolism, thus the widespread consumption of this monosaccharide has been related to steady increasing levels of serum uric acid during the past few decades. Recent evidence has suggested that uric acid may act as a cardiorenal toxin. In this regard, experimental studies have suggested that the primary noxious effect of uric acid occurs inside the cell and is likely the stimulation of oxidative stress. More studies to disclose the harmful mechanisms associated with increasing intracellular uric acid levels after a fructose load are warranted.


Subject(s)
Fructose/adverse effects , Fructose/metabolism , Uric Acid/metabolism , Animals , Humans , Hyperuricemia/chemically induced
20.
Exp Mol Pathol ; 91(1): 478-83, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21596033

ABSTRACT

The density of Angiotensin II (Ang) receptors on tissue surfaces is regulated by multiple hormones, cytokines and metabolic factors and is profoundly affected by various pathological conditions, such as age, diet and environmental conditions. The participation of several cardiovascular risk factors in the regulation of Angiotensin II receptor expression has been incompletely studied. We performed an ex-vivo study with human aortic postsurgical specimens to test the hypothesis that Ang AT1 and AT2 receptor expression in human aortic arteries is associated with the presence of cardiovascular risk factors. We included 31 Mexican patients with coronary artery disease. We evaluated Angiotensin II receptor expression by immunostaining and angiotensin converting enzyme insertion/deletion (ACE I/D) polymorphisms by polymerase chain reaction. AT1 and AT2 receptor expression was increased in the aortic segments from the cardiovascular patients compared with control arteries and in patients with the DD genotype. There was a correlation between increased AT1 receptor expression and the number of cardiovascular risk factors present in the patient. Furthermore, reduction of AT1 expression correlated with the number of drug combinations used in the patients. These correlations were not present with respect to AT2 receptor expression. We suggest that increased AT1 receptor expression is associated with the DD genotype. Thus the presence of several cardiovascular risk factors as well as DD genotype, induce AT1 expression increasing the probability to develop coronary occlusive disease.


Subject(s)
Coronary Stenosis/genetics , Genetic Predisposition to Disease , Receptor, Angiotensin, Type 1/genetics , Adult , Angiotensin Receptor Antagonists/metabolism , Angiotensin-Converting Enzyme Inhibitors/metabolism , Aorta/metabolism , Aorta/pathology , Coronary Stenosis/metabolism , Coronary Stenosis/pathology , Female , Genotype , Humans , Male , Middle Aged , Receptor, Angiotensin, Type 1/metabolism , Receptor, Angiotensin, Type 2/genetics , Receptor, Angiotensin, Type 2/metabolism , Risk Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...